Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$20.81 USD
-0.12 (-0.57%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $20.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For SNDX
-
Syndax: Q2 Earnings Snapshot
-
Syndax Reports Second Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Syndax: Q1 Earnings Snapshot
-
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q1 Earnings Snapshot
-
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
-
Syndax (SNDX) to Report Q4 Earnings: What's in the Cards?
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax: Q2 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Syndax Pharmaceuticals (SNDX) Q2 Earnings Expected to Decline
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release